Reunion Neuroscience Analysis
| REUNDelisted Stock | USD 1.12 0.01 0.90% |
Reunion Neuroscience is overvalued with Real Value of 0.86 and Hype Value of 1.12. The main objective of Reunion Neuroscience delisted stock analysis is to determine its intrinsic value, which is an estimate of what Reunion Neuroscience is worth, separate from its market price. There are two main types of Reunion Neuroscience's stock analysis: fundamental analysis and technical analysis.
The Reunion Neuroscience stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Reunion Neuroscience is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Reunion Stock trading window is adjusted to America/New York timezone.
Reunion |
Reunion Stock Analysis Notes
About 34.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.49. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Reunion Neuroscience recorded a loss per share of 2.51. The entity last dividend was issued on the 6th of October 2020. The firm had 1:5 split on the 17th of August 2022. Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada. Reunion Neuroscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 194 people. To find out more about Reunion Neuroscience learn more at https://www.fieldtriphealth.com.Reunion Neuroscience Investment Alerts
| Reunion Neuroscience is not yet fully synchronised with the market data | |
| Reunion Neuroscience may become a speculative penny stock | |
| Reunion Neuroscience has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (48.49 M) with loss before overhead, payroll, taxes, and interest of (4.29 M). | |
| Reunion Neuroscience currently holds about 48.13 M in cash with (27.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 34.0% of the company outstanding shares are owned by corporate insiders |
Reunion Neuroscience Upcoming and Recent Events
Earnings reports are used by Reunion Neuroscience to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 27th of September 2023 Upcoming Quarterly Report | View | |
| 13th of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 26th of June 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Reunion Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.01 M.About Reunion Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Reunion Neuroscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Reunion shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Reunion Neuroscience. By using and applying Reunion Stock analysis, traders can create a robust methodology for identifying Reunion entry and exit points for their positions.
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada. Reunion Neuroscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 194 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Reunion Neuroscience to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Reunion Stock
If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Transaction History View history of all your transactions and understand their impact on performance |